[(2R,3R,4S,5R,6S)-4,5-diacetyloxy-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy-3-[(Z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate

Details

Top
Internal ID 9837abaf-7cab-487c-8b5d-9b2a493e716d
Taxonomy Phenylpropanoids and polyketides > Flavonoids > Flavonoid glycosides > Flavonoid 3-O-p-coumaroyl glycosides
IUPAC Name [(2R,3R,4S,5R,6S)-4,5-diacetyloxy-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy-3-[(Z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate
SMILES (Canonical) CC(=O)OC1C(C(OC(C1OC(=O)C)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)COC(=O)C=CC5=CC=C(C=C5)O)OC(=O)C=CC6=CC=C(C=C6)O
SMILES (Isomeric) CC(=O)O[C@H]1[C@@H]([C@H](O[C@H]([C@@H]1OC(=O)C)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)COC(=O)/C=C/C5=CC=C(C=C5)O)OC(=O)/C=C\C6=CC=C(C=C6)O
InChI InChI=1S/C43H36O17/c1-22(44)55-41-39(59-35(52)18-8-25-5-13-28(47)14-6-25)33(21-54-34(51)17-7-24-3-11-27(46)12-4-24)58-43(42(41)56-23(2)45)60-40-37(53)36-31(50)19-30(49)20-32(36)57-38(40)26-9-15-29(48)16-10-26/h3-20,33,39,41-43,46-50H,21H2,1-2H3/b17-7+,18-8-/t33-,39-,41+,42-,43+/m1/s1
InChI Key QFYWXPXFEBIELC-ASZZAFOJSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C43H36O17
Molecular Weight 824.70 g/mol
Exact Mass 824.19524968 g/mol
Topological Polar Surface Area (TPSA) 251.00 Ų
XlogP 5.90
Atomic LogP (AlogP) 4.84
H-Bond Acceptor 17
H-Bond Donor 5
Rotatable Bonds 12

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of [(2R,3R,4S,5R,6S)-4,5-diacetyloxy-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy-3-[(Z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8485 84.85%
Caco-2 - 0.8687 86.87%
Blood Brain Barrier - 0.9000 90.00%
Human oral bioavailability - 0.7857 78.57%
Subcellular localzation Mitochondria 0.7223 72.23%
OATP2B1 inhibitior - 0.5745 57.45%
OATP1B1 inhibitior + 0.8326 83.26%
OATP1B3 inhibitior - 0.3029 30.29%
MATE1 inhibitior - 0.9000 90.00%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior + 0.9642 96.42%
P-glycoprotein inhibitior + 0.8206 82.06%
P-glycoprotein substrate - 0.5407 54.07%
CYP3A4 substrate + 0.6953 69.53%
CYP2C9 substrate - 0.6051 60.51%
CYP2D6 substrate - 0.8830 88.30%
CYP3A4 inhibition - 0.7175 71.75%
CYP2C9 inhibition + 0.5170 51.70%
CYP2C19 inhibition - 0.7954 79.54%
CYP2D6 inhibition - 0.9265 92.65%
CYP1A2 inhibition - 0.9390 93.90%
CYP2C8 inhibition + 0.8899 88.99%
CYP inhibitory promiscuity + 0.6264 62.64%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9800 98.00%
Carcinogenicity (trinary) Non-required 0.6631 66.31%
Eye corrosion - 0.9911 99.11%
Eye irritation - 0.9003 90.03%
Skin irritation - 0.8324 83.24%
Skin corrosion - 0.9538 95.38%
Ames mutagenesis - 0.5237 52.37%
Human Ether-a-go-go-Related Gene inhibition - 0.4200 42.00%
Micronuclear + 0.7592 75.92%
Hepatotoxicity - 0.6625 66.25%
skin sensitisation - 0.8443 84.43%
Respiratory toxicity + 0.6222 62.22%
Reproductive toxicity + 0.7333 73.33%
Mitochondrial toxicity + 0.5875 58.75%
Nephrotoxicity - 0.8930 89.30%
Acute Oral Toxicity (c) III 0.6389 63.89%
Estrogen receptor binding + 0.8160 81.60%
Androgen receptor binding + 0.8513 85.13%
Thyroid receptor binding + 0.5679 56.79%
Glucocorticoid receptor binding + 0.7386 73.86%
Aromatase binding - 0.5153 51.53%
PPAR gamma + 0.7300 73.00%
Honey bee toxicity - 0.7476 74.76%
Biodegradation - 0.9000 90.00%
Crustacea aquatic toxicity + 0.5200 52.00%
Fish aquatic toxicity + 0.9671 96.71%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL3729 P22748 Carbonic anhydrase IV 62.2 nM
Ki
via Super-PRED
CHEMBL2326 P43166 Carbonic anhydrase VII 26.6 nM
Ki
via Super-PRED
CHEMBL3242 O43570 Carbonic anhydrase XII 399.7 nM
Ki
via Super-PRED

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.13% 91.11%
CHEMBL1806 P11388 DNA topoisomerase II alpha 98.42% 89.00%
CHEMBL1293249 Q13887 Kruppel-like factor 5 97.26% 86.33%
CHEMBL2345 P51812 Ribosomal protein S6 kinase alpha 3 96.66% 95.64%
CHEMBL1951 P21397 Monoamine oxidase A 95.91% 91.49%
CHEMBL2581 P07339 Cathepsin D 95.80% 98.95%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 93.69% 94.45%
CHEMBL3401 O75469 Pregnane X receptor 93.27% 94.73%
CHEMBL3194 P02766 Transthyretin 92.79% 90.71%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 92.45% 96.09%
CHEMBL3060 Q9Y345 Glycine transporter 2 90.45% 99.17%
CHEMBL4481 P35228 Nitric oxide synthase, inducible 90.13% 94.80%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 86.99% 85.14%
CHEMBL3091268 Q92753 Nuclear receptor ROR-beta 86.51% 95.50%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 86.33% 96.00%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 86.10% 95.56%
CHEMBL242 Q92731 Estrogen receptor beta 85.17% 98.35%
CHEMBL4208 P20618 Proteasome component C5 84.66% 90.00%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 84.44% 99.15%
CHEMBL1929 P47989 Xanthine dehydrogenase 84.36% 96.12%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 83.56% 94.00%
CHEMBL5339 Q5NUL3 G-protein coupled receptor 120 82.82% 95.78%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 81.75% 95.89%
CHEMBL5255 O00206 Toll-like receptor 4 80.66% 92.50%

Cross-Links

Top
PubChem 10418008
NPASS NPC114101
LOTUS LTS0006076
wikiData Q105219856